Australia markets open in 6 hours 49 minutes

Surgery Partners, Inc. (SGRY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.85-0.65 (-2.55%)
As of 01:11PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.23B
Enterprise value 6.09B
Trailing P/E N/A
Forward P/E 22.99
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.17
Price/book (mrq)1.62
Enterprise value/revenue 2.22
Enterprise value/EBITDA 13.66

Trading information

Stock price history

Beta (5Y monthly) 2.74
52-week change 3-35.06%
S&P500 52-week change 322.64%
52-week high 345.79
52-week low 322.05
50-day moving average 328.94
200-day moving average 331.28

Share statistics

Avg vol (3-month) 3927.13k
Avg vol (10-day) 3956.81k
Shares outstanding 5126.61M
Implied shares outstanding 6126.61M
Float 874.36M
% held by insiders 11.23%
% held by institutions 1107.70%
Shares short (15 Apr 2024) 48.6M
Short ratio (15 Apr 2024) 411.02
Short % of float (15 Apr 2024) 417.66%
Short % of shares outstanding (15 Apr 2024) 46.79%
Shares short (prior month 15 Mar 2024) 48.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -0.43%
Operating margin (ttm)19.84%

Management effectiveness

Return on assets (ttm)3.82%
Return on equity (ttm)4.07%

Income statement

Revenue (ttm)2.74B
Revenue per share (ttm)21.84
Quarterly revenue growth (yoy)4.00%
Gross profit (ttm)N/A
EBITDA 533M
Net income avi to common (ttm)-11.9M
Diluted EPS (ttm)-0.09
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)195.9M
Total cash per share (mrq)1.56
Total debt (mrq)3.08B
Total debt/equity (mrq)91.60%
Current ratio (mrq)1.71
Book value per share (mrq)15.79

Cash flow statement

Operating cash flow (ttm)293.8M
Levered free cash flow (ttm)142.69M